BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//International Health Economics Association - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://healtheconomics.org
X-WR-CALDESC:Events for International Health Economics Association
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260525T050000
DTEND;TZID=UTC:20260525T060000
DTSTAMP:20260519T183116
CREATED:20260420T172146Z
LAST-MODIFIED:20260420T172146Z
UID:334975-1779685200-1779688800@healtheconomics.org
SUMMARY:A 10-year scoping review: an inspirational or cautionary tale?
DESCRIPTION:Add to Calendar! \nEver started a project that was meant to be ‘quick and straightforward’? In this webinar\, Associate Professor Nikki McCaffrey will share the story behind a scoping review that took almost a decade to complete before publication in Social Science & Medicine. The talk offers a candid\, slightly irreverent look at scope creep\, opportunity cost\, and the hard calls around when to persist\, pivot\, or cut losses. Short\, honest\, and practical\, with reassurance that messy research journeys are far more common than we admit. \nSpeaker: \nAssociate Professor Nikki McCaffrey is a health economist at Deakin University\, Victoria\, Australia and Head of Cancer Economics. She works at the intersection of health economics\, outcomes research and policy\, with a particular focus on cancer\, palliative and end‑of‑life care\, and the often‑overlooked role of informal carers. Nikki has published 100+ peer‑reviewed papers and secured over $20 million in competitive research funding\, leading multidisciplinary teams across Australia and internationally. She is a co‑founder and co‑lead of the International Health Economics Association Special Interest Group on the Economics of Palliative & End‑of‑Life Care\, and is a strong advocate for applied\, decision‑relevant research that actually gets used.
URL:https://healtheconomics.org/event/a-10-year-scoping-review-an-inspirational-or-cautionary-tale/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260528T080000
DTEND;TZID=UTC:20260528T090000
DTSTAMP:20260519T183116
CREATED:20260325T193218Z
LAST-MODIFIED:20260325T193218Z
UID:334808-1779955200-1779958800@healtheconomics.org
SUMMARY:Biobanks and Genomics in Low- and Middle-Income Countries: Emerging Opportunities for Research and Health Economics Webinar & Panel Discussion
DESCRIPTION:Add to Calendar! \nThis panel discussion will feature short presentations from Professor Segun Fatumo (Chair of Genomic Diversity at Queen Mary University of London and Head of Non-Communicable Disease Genomics at the MRC Uganda Research Unit) and Professor Zhu Chen (College of Economics and Management\, China Agricultural University\, Beijing). The speakers will highlight emerging opportunities in biobanks and genomics\, particularly in low- and middle-income country (LMIC) settings. The panel discussion will then explore how biobank and genomic platforms and data can be leveraged to inform health economic analysis and policy decision-making in LMICs\, followed by an open discussion and concluding remarks. \nModerator: Professor Zanfina Ademi\, Monash University \nPresentation 1:\nName: Professor Segun Fatumo\nRole & organization: Chair of Genomic Diversity at Queen Mary University of London and Head of Non-Communicable Disease Genomics at the MRC Uganda Research Unit\nBio: Professor Segun Fatumo is a globally recognised genomic epidemiologist advancing equitable human genomics research. He is Professor and Chair of Genomic Diversity at Queen Mary University of London and Head of Non-Communicable Disease Genomics at the MRC Uganda Research Unit. His work focuses on genetic determinants of cardiometabolic disease and kidney disease in diverse ancestry populations. He leads major initiatives including KidneyGenAfrica\, BCX-Africa and the Nigerian 100K Genome Project\, supported by international funders such as the MRC\, NIH and Wellcome Trust. Professor Fatumo is widely published\, serves on global advisory boards\, contributes to genomics policy and capacity building in Africa\, and is a frequent keynote speaker and media commentator\nAbstract: The Uganda Genome Resource (UGR) is a well-characterized genomic biobank derived from the long-standing Uganda General Population Cohort\, comprising genotype data (~5\,000 individuals) and whole-genome sequencing (~2\,000 individuals) across 10 ethno-linguistic groups. With rich phenotypic data spanning communicable and non-communicable diseases\, UGR provides a unique platform for advancing genomics\, multi-omics integration\, and precision medicine in African populations. It enables discovery of population-specific variants\, improved disease risk prediction\, and deeper biological insights across diverse ancestries. These opportunities position UGR as a critical resource not only for scientific discovery but also for generating evidence to inform cost-effective health economic strategies and policy decisions in LMICs. \nPresentation 2:\nName: Professor Chen Zhu\nRole & organization: College of Economics and Management\, China Agricultural University\, Beijing\nBio: Chen Zhu is a Professor at the College of Economics and Management\, China Agricultural University. She received her Ph.D. in Agricultural and Resource Economics from the University of Connecticut and her B.S. in Biology from Nanjing University. She currently serves as an Associate Editor for Agribusiness and an Editorial Board Member of Scientific Reports. Dr. Zhu has published more than 50 peer-reviewed articles in economics\, public health\, and interdisciplinary journals. Her research focuses on genoeconomics\, integrating genetic and socioeconomic data to better understand human capital formation\, health behaviors\, and economic decision-making\, with particular interest in applications to rural development and health policy in China. Website: https://zhuchencau.wordpress.com/cv/\nAbstract: This talk introduces a pilot Human Capital and Genoeconomics Survey conducted among rural households in China since 2019. The survey combines rich socioeconomic information\, including human capital\, health behaviors\, fertility\, and household decision-making\, with individual genetic data for about 800 participants in rural China. Using this dataset\, she will explore how genomic variation interacts with environmental conditions\, nutrition\, and local economic contexts to shape health and socioeconomic outcomes. She will argue that small- and medium-scale genomic surveys linked to detailed socioeconomic data can complement large biobanks\, offering a practical framework for advancing genoeconomics research and informing health and development policy in low- and middle-income country settings.
URL:https://healtheconomics.org/event/biobanks-and-genomics-in-low-and-middle-income-countries-emerging-opportunities-for-research-and-health-economics-webinar-panel-discussion/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260629T120000
DTEND;TZID=UTC:20260629T133000
DTSTAMP:20260519T183116
CREATED:20260506T164018Z
LAST-MODIFIED:20260506T203604Z
UID:335106-1782734400-1782739800@healtheconomics.org
SUMMARY:Development Assistance for Health at a Crossroads: Navigating Aid Cuts\, Fragility\, and Financing Trade-offs for Universal Health Coverage
DESCRIPTION:Add to Calendar! \nGlobal health financing is at a turning point. With DAH projected to decline by at least 20% from 2025\, low-income and fragile states face acute risks to essential health services — from HIV and maternal health to supply chains and health information systems. \nJoin us for a webinar bringing together researchers and practitioners to explore the evidence: What do we know about the impact of DAH on health outcomes? What can country experiences like Nigeria tell us about navigating these shifts? And what financing trade-offs must be made to keep UHC within reach? \nThe Webinar will be moderated by Peter Binyaruka (Ifakara Health Institute) and will be featuring presentations by Newton Chagoma (University of Birmingham)\, Jacopo Gabani (World Bank)\, Felix Obi (Results for Development\, Nigeria)\, Sakshi Mohan (University of York)\, and Sophie Witter (Queen Margaret University\, Edinburgh). \nSpeakers \nPeter Binyaruka – Health Economist\, Ifakara Health Institute \n  \n  \n  \nNewton Chagoma – Research Fellow\, University of Birmingham \n  \n  \n  \nJacopo Gabani – World Bank\, Health Economist \n  \n  \n  \nFelix Obi – Country Director for Nigeria & Senior Program Director\, Global Health Practice\, Results for Development (R4D) \n  \n  \n  \nSakshi Mohan – Research Fellow\, Centre for Health Economics (CHE)\, University of York \n  \n  \n\nSophie Witter – Professor of International Health Financing and Health Systems\, Queen Margaret University\, Edinburgh \n 
URL:https://healtheconomics.org/event/development-assistance-for-health-at-a-crossroads-navigating-aid-cuts-fragility-and-financing-trade-offs-for-universal-health-coverage/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260923T110000
DTEND;TZID=UTC:20260923T120000
DTSTAMP:20260519T183116
CREATED:20260507T202740Z
LAST-MODIFIED:20260519T143508Z
UID:335151-1790161200-1790164800@healtheconomics.org
SUMMARY:Health Inequality Aversion in Asia - Early Findings\, Methodological Challenges and Next Steps
DESCRIPTION:Add to Calendar! \nBackground: \nEquity in health has been a concern for long and has been central to aspirations for Universal Health Coverage (UHC)\, an objective enshrined in the Sustainable Development Goals (SDGs). Health Technology Assessment (HTA) has been identified as an approach to support UHC by use of evidence to inform policy on allocation of resources for health\, taking equity and other relevant considerations into account. Equity has featured in health economic research using various methodological approaches and over the past decade\, there have been innovations in methodological approaches to address equity through health economic evaluations\, such as Distributional Cost-effectiveness Analysis (DCEA) and Extended Cost-effectiveness Analysis (ECEA). \nThe Equity Informative Economic Evaluation Special Interest Group (SIG) of the the International Health Economics Association (iHEA) seeks to provide a platform for researchers and “encourage the development and synthesis of methods for using economic evaluation to address equity concerns”. More information is available at the following link: https://healtheconomics.org/sigs/eee/ \nTo further this mandate\, the EIEE SIG proposes hosting a series of webinars spanning the next two years. \nObjectives of the series: \n· To learn and share about equity informative health economic evaluations \n· To connect researchers working on equity informative health economic evaluations and form partnerships \n· To identify potential areas for future research and collaboration on equity informative health economic evaluations \n  \nThe first of the webinar series is: Health Inequality Aversion in Asia – Early Findings\, Methodological Challenges and Next Steps\, with the aim to: \n· To share findings from studies conducted on inequity \n· To learn about methodological challenges and potential applications \n· To identify potential areas for collaboration \nSpeakers: \n \nDr. Xiaoning He is an Associate Professor and Doctoral Supervisor at the School of Pharmaceutical Science and Technology\, Tianjin University.  \nShe was a visiting scholar at the University of Sheffield\, UK\, from September 2019 to March 2020. Her research interests cover pharmacoeconomics\, real-world evidence studies\, and health policy evaluation. She has served as the Principal Investigator (PI) for the General Program and Youth Program of the National Natural Science Foundation of China\, as well as for the General Program and Youth Program of the Tianjin Natural Science Foundation. Additionally\, she acts as a sub-project leader for the Major Program of the National Social Science Fund of China. She has authored more than 70 peer-reviewed journal articles\, among which over 40 are indexed in SCI/SSCI\, published in reputable journals including Value in Health and Pharmacoeconomics. She also contributed to the compilation of the China Guidelines for Pharmacoeconomic Evaluation 2025. She serves as Member and Secretary of the Pharmacoeconomics Committee of the Chinese Pharmaceutical Association\, Standing Committee Member of the Pharmacoeconomics Committee of the China Health Insurance Research Association\, and Member and Secretary of the Pharmacoeconomics Committee of the Tianjin Pharmaceutical Association. \n \nDr. Sitanshu Sekhar Kar is a Professor in the Department of Preventive and Social Medicine\, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)\, Puducherry.  \nHis areas of interest are Epidemiology\, NCD prevention & Health Promotion\, Health System Strengthening\, and Medical Education. He is leading the distributional cost-effective analysis study in India. He is passionate about capacity strengthening of early career researchers and led the inaugural programme through HTAsiaLink. He has contributed to the research community and was the Chief Editor of the International Journal of Medicine and Public Health (2013-2015)\, and a member of the Editorial Board of the Indian Journal of Community & Family Medicine and NTTC Bulletin. He is a reviewer of many national and international peer-reviewed journals like BMC Health\, Health Promotion International\, International Journal of Medicine and Public Health\, Indian Journal of Community Health\, IJOEM\, IJMS\, Journal of Pharmacology and Therapeutics & Indian Journal of Public Health. \n \nDr. Wanrudee Isaranuwatchai\, Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP)\, Thailand and Affiliated Scientist at St. Michael’s Hospital\, and an Associate Professor at the Institute of Health Policy\, Management and Evaluation\, University of Toronto\, in Canada. \nHer research focuses on how to apply health economics and health technology assessment (HTA) in the real-world setting as well as how to advance methods in economic evaluation (EE). She has experience conducting EEs using various methods with specific interest in the potential of big data in health economics and HTA to support evidence generation and policy-making process. \nShe has also collaborated with researchers\, health professionals\, and policy-makers in various areas to help communicate the value of health initiatives using EE. She has contributed to the training on HTA to support health systems in Asia\, Africa\, and North America. Dr. Isaranuwatchai is dedicated to the creation and use of evidence in healthcare decision making. \n \nDr. Stéphane Verguet is an Associate Professor of Global Health in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health and a core faculty member of Harvard University’s Center for Health Decision Science.  \nHis research concerns health systems\, health economics\, and priority setting\, with significant contributions toward incorporating dimensions of equity into the economic evaluation of health policies and priority setting through the modeling of health benefit packages and intersectoral interventions\, via applied economic evaluations. He has co-chaired the Analytics & Metrics Community of Practice of the Research Consortium for School Health & Nutrition since 2021 and has contributed to the World Bank’s Disease Control Priorities since 2009\, most recently as a lead editor for the Universal Health Coverage volume of its fourth edition. He was also a Commissioner of The Lancet Global Health 2050 Commission. Verguet has degrees from the University of California\, Berkeley\, and the École Polytechnique and was previously on the faculty of the University of Washington. \n \nDr. Richard Cookson is a Professor at the Centre for Health Economics\, and Co-Director of the Equity in Health Policy (Equipol) research group. \nHe has helped pioneer “equity-informative” methods of policy analysis\, including distributional cost-effectiveness analysis; health equity indicators for healthcare quality assurance; and methods for investigating public concern for reducing health inequality; and is currently developing microsimulation methods for long-term childhood policy analysis.  He has co-chaired international working groups on equity\, worked in the UK Prime Minister’s Delivery Unit and served on various NHS advisory committees including the National Institute for Health and Care Excellence and the NHS Advisory Committee on Resource Allocation. Richard’s research focuses on equity in health and health care. Richard is an Honorary Public Health Academic\, Office for Health Improvement and Disparities. He has co-chaired various international working groups on equity; served on various NHS advisory groups including the National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Committee 2002-7\, the Public Health Interventions Advisory Committee 2007-9\, the NHS Outcomes Framework Technical Advisory Committee 2012-16 and the NHS Advisory Committee for Resource Allocation 2017-21; and was seconded to the Prime Minister’s Delivery Unit in the Treasury in 2010. Richard holds a BA in Politics\, Philosophy and Economics and a DPhil in Economics from the University of York\, and an MPhil in Economics from the University of Oxford. \nResources\n\nHealth technology assessment – Global\nSelected\n\n\n\n\n\n\nWHO resolution 67.23 – Health intervention and technology assessment in support of universal health coverage\nSEA/RC66/R4 – Health intervention and technology assessment in support of universal health coverage\n\n\n\n\n\n\nO’Rourke B\, Oortwijn W\, Schuller T. The new definition of health technology assessment: A milestone in international collaboration. International journal of technology assessment in health care. 2020 Jun;36(3):187-90.\nDistributional cost-effectiveness analysis (DCEA) – Centre for Health Economics\, University of York\nTutorial: Extended Cost-Effectiveness Analysis
URL:https://healtheconomics.org/event/health-inequality-aversion-in-asia-early-findings-methodological-challenges-and-next-steps/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
END:VCALENDAR